Stock Research for ARFXF

ARFXF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ARFXF Stock Chart & Research Data

The ARFXF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARFXF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ARFXF Due diligence Resources & Stock Charts

The ARFXF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ARFXF Detailed Price Forecast - CNN Money CNN View ARFXF Detailed Summary - Google Finance
Yahoo View ARFXF Detailed Summary - Yahoo! Finance Zacks View ARFXF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ARFXF Trends & Analysis - Trade-Ideas Barrons View ARFXF Major Holders - Barrons
NASDAQ View ARFXF Call Transcripts - NASDAQ Seeking View ARFXF Breaking News & Analysis - Seeking Alpha
Spotlight View ARFXF Annual Report - CompanySpotlight.com OTC Report View ARFXF OTC Short Report - OTCShortReport.com
TradeKing View ARFXF Fundamentals - TradeKing Charts View ARFXF SEC Filings - Bar Chart
WSJ View Historical Prices for ARFXF - The WSJ Morningstar View Performance/Total Return for ARFXF - Morningstar
MarketWatch View the Analyst Estimates for ARFXF - MarketWatch CNBC View the Earnings History for ARFXF - CNBC
StockMarketWatch View the ARFXF Earnings - StockMarketWatch MacroAxis View ARFXF Buy or Sell Recommendations - MacroAxis
Bullish View the ARFXF Bullish Patterns - American Bulls Short Pains View ARFXF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ARFXF Stock Mentions - StockTwits PennyStocks View ARFXF Stock Mentions - PennyStockTweets
Twitter View ARFXF Stock Mentions - Twitter Invest Hub View ARFXF Investment Forum News - Investor Hub
Yahoo View ARFXF Stock Mentions - Yahoo! Message Board Seeking Alpha View ARFXF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ARFXF - SECform4.com Insider Cow View Insider Transactions for ARFXF - Insider Cow
CNBC View ARFXF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ARFXF - OTC Markets
Yahoo View Insider Transactions for ARFXF - Yahoo! Finance NASDAQ View Institutional Holdings for ARFXF - NASDAQ


Stock Charts

FinViz View ARFXF Stock Insight & Charts - FinViz.com StockCharts View ARFXF Investment Charts - StockCharts.com
BarChart View ARFXF Stock Overview & Charts - BarChart Trading View View ARFXF User Generated Charts - Trading View




Latest Financial News for ARFXF


PMN.TO: Exposin’ Those Epitopes
Posted on Monday October 15, 2018

On Thursday, ProMIS (PMN.TO) (ARFXF) announced another milestone with the identification of several potential monoclonal antibody (mAb) candidates that target toxic oligomers for α-synuclein, which is associated with Parkinson’s Disease (PD). Animal studies conducted by Neuron Experts in France examined the neuroprotective effects of the identified antibodies on primary dopaminergic neurons injured by exposure to α-synuclein toxic oligomers. Just last month, ProMIS appointed James Kupiec, MD as Chief Medical Officer, who was Global Clinical Leader for Parkinson’s Disease at Pfizer.


ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson's Disease
Posted on Thursday October 11, 2018

ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson's Disease


Should You Worry About The ProMIS Neurosciences Inc’s (TSE:PMN) Shareholder Register?
Posted on Tuesday September 25, 2018

Every investor in ProMIS Neurosciences Inc (TSE:PMN) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies tendRead More...


ProMIS Neurosciences to Present at Extraordinary Futures Investment Conference
Posted on Monday September 17, 2018

ProMIS Neurosciences to Present at Extraordinary Futures Investment Conference


Stock Market & Investing Books

Enter a stock symbol to view the stock details.